-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Wu25BsGW6zZ/NLOW4b5GE66yopzWM6IvOkxS9OdT1Lzz60t0pwWljfCJaYaGZp23 bjSs8owb32oCulzop6G+kw== 0000891836-07-000129.txt : 20070424 0000891836-07-000129.hdr.sgml : 20070424 20070424170201 ACCESSION NUMBER: 0000891836-07-000129 CONFORMED SUBMISSION TYPE: 424B2 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070424 DATE AS OF CHANGE: 20070424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMS HEALTH INC CENTRAL INDEX KEY: 0001058083 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 061506026 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B2 SEC ACT: 1933 Act SEC FILE NUMBER: 333-140975 FILM NUMBER: 07785121 BUSINESS ADDRESS: STREET 1: 1499 POST ROAD CITY: FAIRFIELD STATE: CT ZIP: 06824 BUSINESS PHONE: 2033194700 MAIL ADDRESS: STREET 1: 1499 POST ROAD CITY: FAIRFIELD STATE: CT ZIP: 06824 424B2 1 sc0055-07.htm PROSPECTUS SUPPLEMENT Prospectus Supplement

Calculation of the Registration Fee

Title of Each Class of Securities Offered Proposed
Maximum Aggregate
Offering Price 		Amount of
Registration Fee(1)
Common Stock $6,043,448.24 $185.53

(1) Calculated in accordance with Rule 457(r) of the Securities Act of 1933.

Prospectus Supplement Filed Pursuant to Rule 424(b)(2)
Registration No. 333-140975

PROSPECTUS SUPPLEMENT
DATED APRIL 20, 2007
(To Prospectus Dated February 28, 2007)

IMS HEALTH INCORPORATED


203,056 Shares of Common Stock

This Prospectus Supplement, dated April 20, 2007 (the “Supplement”), filed by IMS Health Incorporated (the “Company”), supplements certain information contained in the Company’s prospectus, dated February 28, 2007 (as amended and supplemented from time to time, the “Prospectus”). This Supplement is not complete without, and may not be delivered or used except in connection with, the Prospectus, including all amendments and supplements thereto. The Prospectus relates to the public sale of 203,056 shares of our common stock by Goldman, Sachs & Co. that were delivered by the Company to Goldman, Sachs & Co. pursuant to an underwriting agreement, dated April 20, 2007.

We may further amend or supplement the Prospectus from time to time by filing additional amendments or supplements as required. You should read the entire Prospectus and any amendments or supplements carefully before you make an investment decision.

The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities or determined if the Prospectus, or any of the supplements or amendments relating thereto, is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this Supplement is April 20, 2007.

-----END PRIVACY-ENHANCED MESSAGE-----